BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12716247)

  • 1. Lithium carbonate versus cognitive therapy as sequential combination treatment strategies in partial responders to antidepressant medication: an exploratory trial.
    Kennedy SH; Segal ZV; Cohen NL; Levitan RD; Gemar M; Bagby RM
    J Clin Psychiatry; 2003 Apr; 64(4):439-44. PubMed ID: 12716247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
    Kocsis JH; Gelenberg AJ; Rothbaum BO; Klein DN; Trivedi MH; Manber R; Keller MB; Leon AC; Wisniewski SR; Arnow BA; Markowitz JC; Thase ME;
    Arch Gen Psychiatry; 2009 Nov; 66(11):1178-88. PubMed ID: 19884606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
    Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD
    Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
    Rasmussen KG; Mueller M; Rummans TA; Husain MM; Petrides G; Knapp RG; Fink M; Sampson SM; Bailine SH; Kellner CH
    J Clin Psychiatry; 2009 Feb; 70(2):232-7. PubMed ID: 19192459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression.
    Januel D; Poirier MF; D'alche-Biree F; Dib M; Olié JP
    J Affect Disord; 2003 Sep; 76(1-3):191-200. PubMed ID: 12943949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.
    Ivković M; Damjanović A; Jovanović A; Cvetić T; Jasović-Gasić M
    Psychiatr Danub; 2009 Jun; 21(2):187-93. PubMed ID: 19556947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.
    Bauer M; Bschor T; Kunz D; Berghöfer A; Ströhle A; Müller-Oerlinghausen B
    Am J Psychiatry; 2000 Sep; 157(9):1429-35. PubMed ID: 10964859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive therapy vs medications in the treatment of moderate to severe depression.
    DeRubeis RJ; Hollon SD; Amsterdam JD; Shelton RC; Young PR; Salomon RM; O'Reardon JP; Lovett ML; Gladis MM; Brown LL; Gallop R
    Arch Gen Psychiatry; 2005 Apr; 62(4):409-16. PubMed ID: 15809408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.
    Nierenberg AA; Fava M; Trivedi MH; Wisniewski SR; Thase ME; McGrath PJ; Alpert JE; Warden D; Luther JF; Niederehe G; Lebowitz B; Shores-Wilson K; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1519-30; quiz 1665. PubMed ID: 16946176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
    Hollon SD; DeRubeis RJ; Shelton RC; Amsterdam JD; Salomon RM; O'Reardon JP; Lovett ML; Young PR; Haman KL; Freeman BB; Gallop R
    Arch Gen Psychiatry; 2005 Apr; 62(4):417-22. PubMed ID: 15809409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression.
    Mercier MA; Stewart JW; Quitkin FM
    J Clin Psychiatry; 1992 May; 53(5):166-70. PubMed ID: 1592844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive lithium carbonate in nortriptyline-resistant elderly depressed patients.
    Zimmer B; Rosen J; Thornton JE; Perel JM; Reynolds CF
    J Clin Psychopharmacol; 1991 Aug; 11(4):254-6. PubMed ID: 1918424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment failure with a tricyclic antidepressant followed by lithium addition and response to subsequent electroconvulsive therapy.
    Heijnen WT; van den Broek WW; Birkenhäger TK
    J Clin Psychiatry; 2008 Dec; 69(12):1887-91. PubMed ID: 19014754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of cognitive-behavioural therapy plus pharmacotherapy in inpatient treatment of depressive disorders.
    Köhler S; Hoffmann S; Unger T; Steinacher B; Dierstein N; Fydrich T
    Clin Psychol Psychother; 2013; 20(2):97-106. PubMed ID: 22095701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.
    Amsterdam JD; Wang CH; Shwarz M; Shults J
    J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.